Substance
ENCORAFENIB
Global reference: every product and company linked to this substance.
- cas: 1269440-17-6
- ncit: C98283
- pubchem_cid: 50922675
- rxnorm: 2049106
- unii: 8L7891MRB6
BRAFTOVI · encorafenib [INN] · ENCORAFENIB [JAN] · ENCORAFENIB [USAN] · Encorafenib [WHO-DD] · NVP-LGX-818-NXA · NVP-LGX818 · NVP-LGX818-NXA
Revenue by product (1)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| PFIZER INC. COMMON STOCK | BRAFTOVI | Q2 2026 | $223.0M |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (1)
- BRAFTOVI · PFIZER INC. COMMON STOCK